A case of karyomegalic interstitial nephritis without FAN1 mutations in the setting of brentuximab, ifosfamide, and carboplatin exposure

By sjmartinez • November 15, 2024

Leong M, Dai T, Tong L, Nast CC. A case of karyomegalic interstitial nephritis without FAN1 mutations in the setting of brentuximab, ifosfamide, and carboplatin exposure. BMC Nephrol. 2024 Nov 14;25(1):409. doi: 10.1186/s12882-024-03689-6. PMID: 39543462.

Tags: Brentuximab, FAN1, Karyomegalic interstitial nephritis, Nephrology, Publications

CJASN: A Prelude to the Future

Rhee CM; CJASN Editorial Team. CJASN: A Prelude to the Future. Clin J Am Soc Nephrol. 2024 Nov 7. doi: 10.2215/CJN.0000000613. Epub ahead of print.[...]

Establishing a peritoneal dialysis technique survival core outcome measure: A standardised outcomes in nephrology-peritoneal dialysis consensus workshop report

Elphick EH, Manera KE, Viecelli AK, Craig JC, Cho Y, Ju A, Shen JI, Wilkie M, Anumudu S, Boudville N, Chow JS, Davies SJ, Gooden[...]

Proposed US Legislation to Pay Kidney Donors: Counter-productive and Against Global Ethical Standards

Capron AM, Danovitch GM, Cooper M, Ascher NL, Delmonico FL. Proposed US Legislation to Pay Kidney Donors: Counter-productive and Against Global Ethical Standards. Transplantation. 2024[...]